ORSERDU (elacestrant) tablets

ORSERDU is a prescription medicine to treat women who have gone through menopause and adult
men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative,
ESR1-mutated advanced breast cancer or breast cancer that has spread to other parts of the body
(metastatic), and whose disease has progressed after endocrine therapy.

Home | Argatroban Injection

ORSERDU-elacestrant-Price-India
ORSERDU (elacestrant) tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ORSERDU (elacestrant) tablets

Used for the treatment of postmenopausal women or adult men, with ERpositive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

ORSERDU is an estrogen receptor antagonist indicated for: treatment of postmenopausal women or adult men, with ERpositive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.

Elacestrant is used to treat certain types of hormone receptor-positive breast cancer (breast cancer that depends on hormones such as estrogen to grow) in adults who have had disease progression following treatment with at least one other hormone therapies.

Drug (Brand / Generic): ORSERDU / elacestrant
Current Indication: treat breast cancer
Approval Date: Aug 1, 2023

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.